ROMERIO, ALESSIO
ROMERIO, ALESSIO
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Mostra
records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.005 secondi).
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
2020 Romerio, A; Peri, F
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity
2021 Facchini, F; Minotti, A; Luraghi, A; Romerio, A; Gotri, N; Matamoros-Recio, A; Iannucci, A; Palmer, C; Wang, G; Ingram, R; Martin-Santamaria, S; Pirianov, G; De Andrea, M; Valvano, M; Peri, F
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
2022 Luraghi, A; Ferrandi, M; Barassi, P; Arici, M; Hsu, S; Torre, E; Ronchi, C; Romerio, A; Chang, G; Ferrari, P; Bianchi, G; Zaza, A; Rocchetti, M; Peri, F
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants
2023 Romerio, A
| Titolo | Tipologia | Data di pubblicazione | Autori | File |
|---|---|---|---|---|
| Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview | 01 - Articolo su rivista | 2020 | Romerio, APeri, F | |
| Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity | 01 - Articolo su rivista | 2021 | Facchini F. A.Luraghi A.Romerio A.Peri F. + | |
| Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure | 01 - Articolo su rivista | 2022 | Andrea LuraghiMartina AriciEleonora TorreCarlotta RonchiAlessio RomerioAntonio ZazaMarcella RocchettiFrancesco Peri + | |
| Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants | 07 - Tesi di dottorato Bicocca post 2009 | 2023 | ROMERIO, ALESSIO |